ABG 30 (Morphine sulphate extended-release 30 mg)

Pill imprint ABG 30 has been identified as Morphine sulphate extended-release 30 mg.

Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.

See also related documents.

Imprint Search

Images for ABG 30

Morphine sulphate extended-release 30 mg ABG 30
Morphine sulphate extended-release 30 mg ABG 30
Morphine sulphate extended-release
30 mg
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Watson Pharmaceuticals
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42858-0802 Rhodes Pharmaceuticals
00591-3741 Watson Pharmaceuticals, Inc. (now Actavis, Inc)
66336-0173 Dispensing Solutions Inc. (repackager)
49999-0846 Lake Erie Medical and Surgical Supply (repackager)
55887-0092 Diversified Healthcare Services Inc (repackager)
10544-0379 Blenheim Pharmacal Inc (repackager)
16590-0607 Stat RX USA LLC (repackager)
54868-4033 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.